Neuroscience

In a significant development for the field of neurodegenerative medicine, updated data released in late 2025 regarding the investigational gene therapy AMT-130 indicates a potential breakthrough in Huntington’s treatment. According to reports covering the ongoing Phase I/II clinical trials by biotechnology firm uniQure, the therapy has demonstrated the ability to slow disease progression by approximately…